Role of Epigenetics in Cancer Genomics

Role of Epigenetics in Cancer Genomics

Amit Nagal
Copyright: © 2016 |Pages: 13
ISBN13: 9781466687264|ISBN10: 1466687266|EISBN13: 9781466687271
DOI: 10.4018/978-1-4666-8726-4.ch011
Cite Chapter Cite Chapter

MLA

Nagal, Amit. "Role of Epigenetics in Cancer Genomics." Software Innovations in Clinical Drug Development and Safety, edited by Partha Chakraborty and Amit Nagal, IGI Global, 2016, pp. 234-246. https://doi.org/10.4018/978-1-4666-8726-4.ch011

APA

Nagal, A. (2016). Role of Epigenetics in Cancer Genomics. In P. Chakraborty & A. Nagal (Eds.), Software Innovations in Clinical Drug Development and Safety (pp. 234-246). IGI Global. https://doi.org/10.4018/978-1-4666-8726-4.ch011

Chicago

Nagal, Amit. "Role of Epigenetics in Cancer Genomics." In Software Innovations in Clinical Drug Development and Safety, edited by Partha Chakraborty and Amit Nagal, 234-246. Hershey, PA: IGI Global, 2016. https://doi.org/10.4018/978-1-4666-8726-4.ch011

Export Reference

Mendeley
Favorite

Abstract

Epigenetics is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. ChIP-seq, is a method used to analyze protein interactions with DNA. It is a type of epigenetic analysis technique. Chromatin immunoprecipitation coupled with massive parallel sequencing (ChIP-seq) is gaining popularity day by day because of its clinical significance. It is a very effective tool in diagnosis of disease such as cancer. ChIP-seq is found to be very effective tool in understanding basic regulatory mechanism, cell differentiation study and studying disease processes with the decreasing cost of sequencing, ChIP-seq has become an indispensable tool for studying gene regulation and epigenetic mechanisms. The Present review explores epigenetic methods, pipeline and its role in cancer.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.